Tempest Therapeutics Ownership 2024 | Who Owns Tempest Therapeutics Now?
Institutional Ownership
1.36%
Insider Ownership
0.24%
Retail Ownership
98.40%
Institutional Holders
7.00
Tempest Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BLACKROCK INC. | 2.47% | - | 550,241 | 42,046 | 8.27% | 1,205,028 | Jun 30, 2024 |
FMR LLC | 1.94% | 0.00% | 431,932 | -50 | -0.01% | 945,931 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.79% | - | 176,193 | - | - | 385,862 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.69% | - | 154,241 | 22,158 | 16.78% | 337,830 | Jun 30, 2024 |
FIL LTD | 0.58% | 0.00% | 129,579 | - | - | 283,778 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.47% | 0.04% | 105,600 | - | - | 231,264 | Jun 30, 2024 |
GSA CAPITAL PARTNERS LLP | 0.45% | 0.02% | 101,043 | 101,043 | 100.00% | 221,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.28% | - | 62,736 | 25,945 | 70.52% | 137,392 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.28% | 0.01% | 62,027 | 33,453 | 117.08% | 136,000 | Jun 30, 2024 |
DAVENPORT & CO LLC | 0.22% | 0.00% | 50,000 | 50,000 | 100.00% | 109,500 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.19% | - | 43,257 | 228 | 0.53% | 94,733 | Jun 30, 2024 |
STATE STREET CORP | 0.19% | - | 41,492 | - | - | 90,867,000 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.18% | 0.00% | 40,750 | 26,750 | 191.07% | 89,243 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.11% | 0.00% | 25,378 | -772 | -2.95% | 55,565 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.11% | - | 25,084 | 25,084 | 100.00% | 54,934 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.11% | 0.00% | 24,572 | - | - | 53,813 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.09% | - | 20,354 | -1 | -0.00% | 44,575,000 | Jun 30, 2024 |
MAYTECH GLOBAL INVESTMENTS, LLC | 0.04% | 0.00% | 10,000 | 10,000 | 100.00% | 21,900 | Jun 30, 2024 |
PARALLEL ADVISORS, LLC | 0.00% | - | 236 | 236 | 100.00% | 517 | Jun 30, 2024 |
CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 133 | - | - | 279 | Jun 30, 2024 |
Tempest Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 2.47% of the company's total share outstanding, currently valued at $1.21M. The top 10 institutional shareholders own together 8.20% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
IKARIAN CAPITAL, LLC | 0.47% | 0.04% | 105,600 | - | - | 231,264 | Jun 30, 2024 |
GSA CAPITAL PARTNERS LLP | 0.45% | 0.02% | 101,043 | 101,043 | 100.00% | 221,000 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.28% | 0.01% | 62,027 | 33,453 | 117.08% | 136,000 | Jun 30, 2024 |
MAYTECH GLOBAL INVESTMENTS, LLC | 0.04% | 0.00% | 10,000 | 10,000 | 100.00% | 21,900 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.18% | 0.00% | 40,750 | 26,750 | 191.07% | 89,243 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.11% | 0.00% | 24,572 | - | - | 53,813 | Jun 30, 2024 |
DAVENPORT & CO LLC | 0.22% | 0.00% | 50,000 | 50,000 | 100.00% | 109,500 | Jun 30, 2024 |
FIL LTD | 0.58% | 0.00% | 129,579 | - | - | 283,778 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.11% | 0.00% | 25,378 | -772 | -2.95% | 55,565 | Jun 30, 2024 |
FMR LLC | 1.94% | 0.00% | 431,932 | -50 | -0.01% | 945,931 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.69% | - | 154,241 | 22,158 | 16.78% | 337,830 | Jun 30, 2024 |
BLACKROCK INC. | 2.47% | - | 550,241 | 42,046 | 8.27% | 1,205,028 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.11% | - | 25,084 | 25,084 | 100.00% | 54,934 | Jun 30, 2024 |
PARALLEL ADVISORS, LLC | 0.00% | - | 236 | 236 | 100.00% | 517 | Jun 30, 2024 |
MORGAN STANLEY | 0.28% | - | 62,736 | 25,945 | 70.52% | 137,392 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.19% | - | 43,257 | 228 | 0.53% | 94,733 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.09% | - | 20,354 | -1 | -0.00% | 44,575,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.79% | - | 176,193 | - | - | 385,862 | Jun 30, 2024 |
STATE STREET CORP | 0.19% | - | 41,492 | - | - | 90,867,000 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 15 | -7,980 | -99.81% | 33 | Jun 30, 2024 |
The largest Tempest Therapeutics shareholder by % of total assets is IKARIAN CAPITAL, LLC. The company owns 105.60K shares of Tempest Therapeutics (TPST), representing 0.04% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GSA CAPITAL PARTNERS LLP | 0.45% | 0.02% | 101,043 | 101,043 | 100.00% | 221,000 | Jun 30, 2024 |
DAVENPORT & CO LLC | 0.22% | 0.00% | 50,000 | 50,000 | 100.00% | 109,500 | Jun 30, 2024 |
BLACKROCK INC. | 2.47% | - | 550,241 | 42,046 | 8.27% | 1,205,028 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | 0.28% | 0.01% | 62,027 | 33,453 | 117.08% | 136,000 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.18% | 0.00% | 40,750 | 26,750 | 191.07% | 89,243 | Jun 30, 2024 |
MORGAN STANLEY | 0.28% | - | 62,736 | 25,945 | 70.52% | 137,392 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.11% | - | 25,084 | 25,084 | 100.00% | 54,934 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.69% | - | 154,241 | 22,158 | 16.78% | 337,830 | Jun 30, 2024 |
MAYTECH GLOBAL INVESTMENTS, LLC | 0.04% | 0.00% | 10,000 | 10,000 | 100.00% | 21,900 | Jun 30, 2024 |
PARALLEL ADVISORS, LLC | 0.00% | - | 236 | 236 | 100.00% | 517 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.19% | - | 43,257 | 228 | 0.53% | 94,733 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 27 | - | - | 59 | Jun 30, 2024 |
CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 133 | - | - | 279 | Jun 30, 2024 |
STATE STREET CORP | 0.19% | - | 41,492 | - | - | 90,867,000 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.79% | - | 176,193 | - | - | 385,862 | Jun 30, 2024 |
FIL LTD | 0.58% | 0.00% | 129,579 | - | - | 283,778 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.11% | 0.00% | 24,572 | - | - | 53,813 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.47% | 0.04% | 105,600 | - | - | 231,264 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.09% | - | 20,354 | -1 | -0.00% | 44,575,000 | Jun 30, 2024 |
WHITTIER TRUST CO | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Tempest Therapeutics's largest institutional buyer is GSA CAPITAL PARTNERS LLP. The company purchased 101.04K stocks of TPST, valued at $221.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SIMPLEX TRADING, LLC | - | - | - | -37,820 | -100.00% | - | Jun 30, 2024 |
BANK OF MONTREAL /CAN/ | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
HRT FINANCIAL LP | - | - | - | -13,040 | -100.00% | - | Jun 30, 2024 |
XTX TOPCO LTD | - | - | - | -10,773 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -10,685 | -100.00% | - | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | - | 15 | -7,980 | -99.81% | 33 | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -921 | -100.00% | - | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.11% | 0.00% | 25,378 | -772 | -2.95% | 55,565 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -98 | -100.00% | - | Jun 30, 2024 |
FMR LLC | 1.94% | 0.00% | 431,932 | -50 | -0.01% | 945,931 | Jun 30, 2024 |
WHITTIER TRUST CO OF NEVADA INC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
WHITTIER TRUST CO | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.09% | - | 20,354 | -1 | -0.00% | 44,575,000 | Jun 30, 2024 |
IKARIAN CAPITAL, LLC | 0.47% | 0.04% | 105,600 | - | - | 231,264 | Jun 30, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.11% | 0.00% | 24,572 | - | - | 53,813 | Jun 30, 2024 |
FIL LTD | 0.58% | 0.00% | 129,579 | - | - | 283,778 | Jun 30, 2024 |
VANGUARD GROUP INC | 0.79% | - | 176,193 | - | - | 385,862 | Jun 30, 2024 |
STATE STREET CORP | 0.19% | - | 41,492 | - | - | 90,867,000 | Jun 30, 2024 |
CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | - | 133 | - | - | 279 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 27 | - | - | 59 | Jun 30, 2024 |
As of Jun 30 2024, Tempest Therapeutics's biggest institutional seller is SIMPLEX TRADING, LLC. The company sold -37.82K shares of TPST, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
GSA CAPITAL PARTNERS LLP | 0.45% | 0.02% | 101,043 | 101,043 | 100.00% | 221,000 | Jun 30, 2024 |
DAVENPORT & CO LLC | 0.22% | 0.00% | 50,000 | 50,000 | 100.00% | 109,500 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | 0.11% | - | 25,084 | 25,084 | 100.00% | 54,934 | Jun 30, 2024 |
PARALLEL ADVISORS, LLC | 0.00% | - | 236 | 236 | 100.00% | 517 | Jun 30, 2024 |
Tempest Therapeutics's largest new institutional shareholder by number of shares is GSA CAPITAL PARTNERS LLP, purchased 101.04K shares, valued at $221.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SIMPLEX TRADING, LLC | - | - | - | -37,820 | -100.00% | - | Jun 30, 2024 |
BANK OF MONTREAL /CAN/ | - | - | - | -20,000 | -100.00% | - | Jun 30, 2024 |
HRT FINANCIAL LP | - | - | - | -13,040 | -100.00% | - | Jun 30, 2024 |
XTX TOPCO LTD | - | - | - | -10,773 | -100.00% | - | Jun 30, 2024 |
GROUP ONE TRADING, L.P. | - | - | - | -10,685 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -921 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -98 | -100.00% | - | Jun 30, 2024 |
WHITTIER TRUST CO OF NEVADA INC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
WHITTIER TRUST CO | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Tempest Therapeutics's largest sold out institutional shareholder by shares sold is SIMPLEX TRADING, LLC, sold -37.82K shares, valued at -, as of undefined.
Tempest Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY COMMONWEALTH TRUST | 0.00% | 8,933 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 121,597 | 31,944 | 35.63% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 174,007 | -174,007 | -50.00% | Mar 31, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,359 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 3,628 | - | - | Feb 29, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 1,135 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 508 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 800 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,500 | - | - | Jan 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 10,173 | - | - | Jan 31, 2024 |
Tempest Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 8.93K shares, compromising 0.00% of its total assets.
Tempest Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 7 | -78.13% |
31 Mar, 24 | 32 | -11.11% |
31 Dec, 23 | 36 | 50.00% |
30 Sep, 23 | 24 | 9.09% |
30 Jun, 23 | 22 | 29.41% |
31 Mar, 23 | 17 | 30.77% |
31 Dec, 22 | 13 | -7.14% |
30 Sep, 22 | 14 | -6.67% |
30 Jun, 22 | 15 | 15.38% |
31 Mar, 22 | 13 | -18.75% |
31 Dec, 21 | 16 | -15.79% |
30 Sep, 21 | 19 | -9.52% |
30 Jun, 21 | 21 | - |
As of 30 Jun 24, 7 institutions are holding Tempest Therapeutics's shares, representing a decrease of -78.13% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 301,721 | -83.82% |
31 Mar, 24 | 1,864,298 | -15.77% |
31 Dec, 23 | 2,213,399 | -35.12% |
30 Sep, 23 | 3,411,773 | -10.86% |
30 Jun, 23 | 3,827,439 | 23.07% |
31 Mar, 23 | 3,109,866 | 1.38% |
31 Dec, 22 | 3,067,685 | -0.44% |
30 Sep, 22 | 3,081,180 | -1.05% |
30 Jun, 22 | 3,113,830 | 48.21% |
31 Mar, 22 | 2,100,895 | -10.59% |
31 Dec, 21 | 2,349,772 | 7.28% |
30 Sep, 21 | 2,190,289 | 19.36% |
30 Jun, 21 | 1,835,086 | - |
Tempest Therapeutics (TPST) has 301.72K shares outstanding as of 30 Jun 24, down -83.82% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 1.36% | 0.93% |
31 Mar, 24 | 12.09% | 4.92% |
31 Dec, 23 | 15.67% | 2.68% |
30 Sep, 23 | 24.19% | 3.13% |
30 Jun, 23 | 27.81% | 5.45% |
31 Mar, 23 | 22.60% | 3.20% |
31 Dec, 22 | 26.56% | 5.20% |
30 Sep, 22 | 22.60% | 3.12% |
30 Jun, 22 | 26.91% | 3.13% |
31 Mar, 22 | 29.31% | 2.40% |
31 Dec, 21 | 34.98% | 3.29% |
30 Sep, 21 | 32.60% | 4.37% |
30 Jun, 21 | 27.32% | - |
As of 30 Jun 24, Tempest Therapeutics is held by 1.36% institutional shareholders, representing a 0.93% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 6 | -60.00% |
31 Mar, 24 | 15 | -42.31% |
31 Dec, 23 | 26 | 225.00% |
30 Sep, 23 | 8 | -38.46% |
30 Jun, 23 | 13 | 62.50% |
31 Mar, 23 | 8 | 100.00% |
31 Dec, 22 | 4 | - |
30 Sep, 22 | 4 | -20.00% |
30 Jun, 22 | 5 | - |
31 Mar, 22 | 5 | - |
31 Dec, 21 | 5 | -58.33% |
30 Sep, 21 | 12 | -42.86% |
30 Jun, 21 | 21 | - |
6 institutional shareholders have increased their position in TPST stock as of 30 Jun 24 compared to 15 in the previous quarter (a -60.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | - | -100.00% |
31 Mar, 24 | 5 | - |
31 Dec, 23 | 5 | -28.57% |
30 Sep, 23 | 7 | 133.33% |
30 Jun, 23 | 3 | - |
31 Mar, 23 | 3 | 50.00% |
31 Dec, 22 | 2 | -50.00% |
30 Sep, 22 | 4 | -20.00% |
30 Jun, 22 | 5 | 66.67% |
31 Mar, 22 | 3 | -40.00% |
31 Dec, 21 | 5 | 66.67% |
30 Sep, 21 | 3 | - |
30 Jun, 21 | - | - |
- institutional shareholders have reduced their position in TPST stock as of 30 Jun 24 compared to 5 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 7 | -78.13% | 301,721 | -83.82% | 1.36% | 0.93% | 6 | -60.00% | - | -100.00% |
31 Mar, 24 | 32 | -11.11% | 1,864,298 | -15.77% | 12.09% | 4.92% | 15 | -42.31% | 5 | - |
31 Dec, 23 | 36 | 50.00% | 2,213,399 | -35.12% | 15.67% | 2.68% | 26 | 225.00% | 5 | -28.57% |
30 Sep, 23 | 24 | 9.09% | 3,411,773 | -10.86% | 24.19% | 3.13% | 8 | -38.46% | 7 | 133.33% |
30 Jun, 23 | 22 | 29.41% | 3,827,439 | 23.07% | 27.81% | 5.45% | 13 | 62.50% | 3 | - |
31 Mar, 23 | 17 | 30.77% | 3,109,866 | 1.38% | 22.60% | 3.20% | 8 | 100.00% | 3 | 50.00% |
31 Dec, 22 | 13 | -7.14% | 3,067,685 | -0.44% | 26.56% | 5.20% | 4 | - | 2 | -50.00% |
30 Sep, 22 | 14 | -6.67% | 3,081,180 | -1.05% | 22.60% | 3.12% | 4 | -20.00% | 4 | -20.00% |
30 Jun, 22 | 15 | 15.38% | 3,113,830 | 48.21% | 26.91% | 3.13% | 5 | - | 5 | 66.67% |
31 Mar, 22 | 13 | -18.75% | 2,100,895 | -10.59% | 29.31% | 2.40% | 5 | - | 3 | -40.00% |
31 Dec, 21 | 16 | -15.79% | 2,349,772 | 7.28% | 34.98% | 3.29% | 5 | -58.33% | 5 | 66.67% |
30 Sep, 21 | 19 | -9.52% | 2,190,289 | 19.36% | 32.60% | 4.37% | 12 | -42.86% | 3 | - |
30 Jun, 21 | 21 | - | 1,835,086 | - | 27.32% | - | 21 | - | - | - |
Tempest Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Tempest Therapeutics's stock was made by Versant Venture Capital VI, L.P. on Aug 12 2024, selling 400,000 shares at $1.35 per share (valued at $540.04K). The last insider buy of TPST was made by Brady Stephen R on Jul 08 2024, buying 35,000 shares at $2.11 per share (worth $73.85K).
Tempest Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 2 | 2 | 100.00% |
Q2 2024 | 5 | - | - |
Q1 2024 | 4 | - | - |
Q4 2023 | 4 | - | - |
Q2 2023 | 4 | - | - |
Q1 2023 | 5 | - | - |
Q4 2022 | 1 | - | - |
Q3 2022 | - | 1 | - |
Q2 2022 | 14 | 1 | 1400.00% |
Q1 2022 | 7 | - | - |
Q4 2021 | - | - | - |
Q3 2021 | 11 | - | - |
Q2 2021 | 24 | 1 | 2400.00% |
Q1 2021 | 3 | 9 | 33.33% |
Q2 2020 | 12 | - | - |
Q1 2020 | 6 | - | - |
Q4 2019 | 1 | - | - |
Q3 2019 | 2 | 3 | 66.67% |
Q2 2019 | 9 | - | - |
Q1 2019 | 11 | - | - |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Tempest Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 2 | 2 | 100.00% |
Q2 2024 | 1 | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | 1 | - | - |
Q1 2022 | 2 | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | - | - | - |
Q2 2020 | - | - | - |
Q1 2020 | - | - | - |
Q4 2019 | - | - | - |
Q3 2019 | - | - | - |
Q2 2019 | - | - | - |
Q1 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 2 open market buy trades and 2 open market sell trades of Tempest Therapeutics's stocks.
Tempest Therapeutics Peer Ownership
Ticker | Company |
---|---|
OLMA | Olema Pharmaceuticals, Inc. |
SANA | Sana Biotechnology, Inc. |
CGEM | Cullinan Oncology, Inc. |
ZNTL | Zentalis Pharmaceuticals, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
IKNA | Ikena Oncology, Inc. |
SCPS | Scopus BioPharma Inc. |
LYEL | Lyell Immunopharma, Inc. |
AKTX | Akari Therapeutics, Plc |
GLUE | Monte Rosa Therapeutics, Inc. |
RNXT | RenovoRx, Inc. |
RZLT | Rezolute, Inc. |
INDP | Indaptus Therapeutics, Inc. |
PCSA | Processa Pharmaceuticals, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
LIFE | aTyr Pharma, Inc. |
CBIO | Gyre Therapeutics, Inc. |
FBRX | Forte Biosciences, Inc. |
TPST Ownership FAQ
Who Owns Tempest Therapeutics?
Tempest Therapeutics is owned by institutional shareholders (1.36%), insiders (0.24%), and public (98.40%). The largest institutional shareholder of Tempest Therapeutics is BLACKROCK INC. (2.47% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.00% of total shares).
Who are the major institutional shareholders of Tempest Therapeutics?
Tempest Therapeutics's major institutional shareholders are BLACKROCK INC., FMR LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and FIL LTD. The top five shareholders own together 6.49% of the company's share outstanding.
How many Tempest Therapeutics shareholders are there?
As of Jun 2024, there are 7 institutional shareholders of Tempest Therapeutics.
What percentage of Tempest Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 550.24K shares of Tempest Therapeutics, representing 2.47% of the company's total shares outstanding, valued at $1.21M (as of Jun 2024).
What percentage of Tempest Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 431.93K shares of Tempest Therapeutics (TPST), compromising 1.94% of the company, valued at $945.93K.
What percentage of Tempest Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Tempest Therapeutics. The company owns 176.19K of the company's shares outstanding (worth $385.86K).